- Home
- AXSM vs APLE Comparison
AXSM vs APLE Comparison
Compare AXSM & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- APLE
- Stock Information
- Founded
- AXSM 2012
- APLE 2007
- Country
- AXSM United States
- APLE United States
- Employees
- AXSM N/A
- APLE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- APLE Real Estate Investment Trusts
- Sector
- AXSM Health Care
- APLE Real Estate
- Exchange
- AXSM Nasdaq
- APLE Nasdaq
- Market Cap
- AXSM 4.4B
- APLE 3.6B
- IPO Year
- AXSM 2015
- APLE 2015
- Fundamental
- Price
- AXSM $98.19
- APLE $15.73
- Analyst Decision
- AXSM Strong Buy
- APLE Hold
- Analyst Count
- AXSM 14
- APLE 3
- Target Price
- AXSM $124.93
- APLE $17.00
- AVG Volume (30 Days)
- AXSM 536.9K
- APLE 1.7M
- Earning Date
- AXSM 11-12-2024
- APLE 11-04-2024
- Dividend Yield
- AXSM N/A
- APLE 6.11%
- EPS Growth
- AXSM N/A
- APLE 23.65
- EPS
- AXSM N/A
- APLE 0.86
- Revenue
- AXSM $338,457,000.00
- APLE $1,410,888,000.00
- Revenue This Year
- AXSM $40.67
- APLE N/A
- Revenue Next Year
- AXSM $69.27
- APLE $2.68
- P/E Ratio
- AXSM N/A
- APLE $18.30
- Revenue Growth
- AXSM 51.47
- APLE 6.04
- 52 Week Low
- AXSM $60.28
- APLE $13.60
- 52 Week High
- AXSM $105.00
- APLE $17.90
- Technical
- Relative Strength Index (RSI)
- AXSM 61.45
- APLE 58.96
- Support Level
- AXSM $90.86
- APLE $15.30
- Resistance Level
- AXSM $105.00
- APLE $16.05
- Average True Range (ATR)
- AXSM 4.06
- APLE 0.34
- MACD
- AXSM 0.44
- APLE -0.01
- Stochastic Oscillator
- AXSM 64.04
- APLE 72.73
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.